常规HIV检测与结局:台湾基于人群的队列研究
该研究基于台湾HIV/AIDS登记库,比较1986-2014年确诊的28,674例HIV感染者中,经常规检测(特定场所主动提供、可选择退出)与个体风险检测确诊者的结局。常规检测与晚期诊断风险降低80%、HIV相关死亡风险降低37%、全因死亡风险降低27%相关。在全民健康覆盖下,于针对性场所扩大常规HIV检测可能同时改善疫情控制和临床结局。
要点
- 常规HIV检测与晚期诊断风险降低80%相关(AOR=0.20,95%CI=0.18-0.23)。
- 常规检测与HIV相关死亡风险降低37%相关(aHR=0.63,95%CI=0.53-0.75)。
- 常规检测与全因死亡风险降低27%相关(aHR=0.73,95%CI=0.67-0.79)。
核心结论
- 常规HIV检测与晚期诊断、HIV相关死亡和全因死亡风险降低相关。
- 在全民健康覆盖下,于针对性场所扩大常规检测可能改善疫情控制和临床结局。
研究设计与样本
- 纳入1986-2014年确诊的28,674例HIV感染者,其中8,431例(29%)经常规检测确诊,18,305例(64%)经个体风险检测确诊。
- 按HIV确诊年份匹配,并调整年龄、性别、传播途径和社会经济地位;分析于2019-2020年进行。
主要发现
- 常规检测与晚期HIV诊断可能性降低80%相关(AOR=0.20,95%CI=0.18-0.23,p<0.001)。
- 常规检测与HIV相关死亡风险降低37%相关(调整风险比=0.63,95%CI=0.53-0.75,p<0.001)。
- 常规检测与全因死亡风险降低27%相关(调整风险比=0.73,95%CI=0.67-0.79,p<0.001)。
- 平均随访时间为6.2年。
临床怎么用
- 在特定场所实施常规、可选择退出的HIV检测,可能促进早期诊断并改善生存结局。
- 全民健康覆盖背景下,可考虑在针对性场所扩大常规HIV检测以辅助疫情控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Routine HIV testing is expected to facilitate early diagnosis and treatment. Nevertheless, to date, limited data are available on the presumed benefit of early detection with improved outcomes through routine HIV testing. METHODS: This study was based on the Taiwan national HIV/AIDS registry, with follow-up data validated through December 31, 2014. Outcomes of people diagnosed with HIV infection through the routine (routinely offered in specific settings, opt-out) versus through nonroutine (individual risk-based) testing were compared. The main outcomes of the study were late diagnosis, HIV-related mortality, and all-cause mortality. Individuals were matched by year of HIV diagnosis and adjusted for age, sex, transmission routes, and SES. Analyses were conducted in 2019-2020. RESULTS: This study included all 28,674 people diagnosed with HIV infection during 1986-2014 (8,431 [29%] by routine testing, 18,305 [64%] by individual risk-based testing) with a mean follow-up time of 6.2 years. Routine testing was associated with an 80% lower likelihood of late HIV diagnosis (AOR=0.20, 95% CI=0.18, 0.23, p<0.001), a 37% lower HIV-related mortality (adjusted hazard ratio=0.63, 95% CI=0.53, 0.75, p<0.001), and a 27% lower all-cause mortality (adjusted hazard ratio=0.73, 95% CI=0.67, 0.79, p<0.001). CONCLUSIONS: Routine HIV testing was associated with highly favorable outcomes, including decreased late diagnosis, lower HIV-related mortality, and lower all-cause mortality, among people diagnosed with HIV infection. Under universal health coverage, expanding routine HIV testing in well-targeted settings may improve both HIV epidemic control for society and clinical outcomes for people living with HIV.
引用
- Chen YH, Fang CT, Shih MC, et al. Routine HIV Testing and Outcomes: A Population-Based Cohort Study in Taiwan. Am J Prev Med. 2021. PMID: 34649736. doi:10.1016/j.amepre.2021.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。